Research news:
- 21 May 2012
New research brings us closer to understanding the cause of spinal muscular atrophy Researchers in the US have uncovered further clues about why having low levels of the SMN protein causes the symptoms seen in spinal muscular atrophy (SMA). - 18 May 2012
New registry brings hope for families with myotonic dystrophy A new patient registry for individuals with myotonic dystrophy type 1, funded through a partnership between the Muscular Dystrophy Campaign and the Myotonic Dystrophy Support Group, is being launched. - 8 May 2012
New gene causing congenital muscular dystrophy discovered Prof Francesco Muntoni and an international group of scientists have discovered that mutations in the isoprenoid synthase domain containing gene (ISPD) can cause congenital muscular dystrophy. - 2 May 2012
New collaboration to support omigapil clinical trial for congenital muscular dystrophy Santhera Pharmaceuticals have announced a collaboration that will help to facilitate the smooth transition of omigapil from the laboratory through to the clinic. - 30 April 2012
Positive results from phase 1 safety trial of SMA drug Repligen has just announced positive results from its phase 1 safety trial of RG3039 for spinal muscular atrophy. - 19 April 2012
AVI Biopharma release new results from phase 2b exon skipping trial AVI Biopharma has announced preliminary results of their phase 2b study of Eteplirsen for Duchenne muscular dystrophy. - 5 April 2012
New drug a potential treatment for Duchenne muscular dystrophy Scientists have shown that increasing the amount of a protein called heat shock protein 72 can have a beneficial effect in a mouse model of Duchenne muscular dystrophy. - 14 March 2012
Update on BIO-NMD: A research project looking into Duchenne, Becker, Ullrich and Bethlem muscular dystrophies An update on the progress of BIO-NMD - an EU funded project searching for biomarkers - 6 March 2012
Our response to enquiry into allowing prevention of mitochondrial myopathy The Muscular Dystrophy Campaign and the AMRC have submitted a joint response to a call for evidence from the Nuffield Council on Bioethics - 2 March 2012
Our research at the forefront of genetic diagnostics Scientists at The University of Nottingham have used 'next-generation' DNA sequencing technology to correct the diagnosis of a patient with muscular dystrophy.
